28 completed. 28 Phase 2, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 28 | Completed 28 |
| Phase 3 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow Pleural Effusion: new trials by email Literature Review of Pleural Effusion trials Research Report on Pleural Effusion
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Chemical vs Mechanical Pleural Adhesiolysis for Liberation of Captive Pleura in Stacked Effusion Intrapleural Hydrogen Peroxide (H_2O_2), Intrapleural Corticosteroids, Thoracoscopic Mechanical Pleurolysis - Pleural Infection, Pleural Adhesions | Phase 2 | Completed | Delta University for Science and Technology | 36 | 2026-03-26 | 2026-07-20 |
| Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma RSO-021 - Malignant Pleural Effusion, Malignant Pleural Mesothelioma | Phase 1 / Phase 2 | Completed | RS Oncology LLC | 50 | 2022-03-31 | 2026-07-24 |
| A Study to Evaluate LTI-01 in Patients With Infected, Non-draining Pleural Effusions LTI-01, Placebo - Pleural Effusion | Phase 2 | Completed | Rein Therapeutics | 44 | 2020-09-26 | 2023-03-30 |
| Intrapleural Instillation of the Nivolumab in Cancer Patients With Pleural Effusion. Nivolumab - Renal Cell Cancer Metastatic, Non-small Cell Lung Cancer Metastatic | Phase 2 | Completed | Kidney Cancer Research Bureau | 26 | 2020-08-10 | 2023-03-08 |
| Persistent Pleural Effusion Treatment Following Cardiothoracic Surgery by Platelet-Fibrin Glue Platelet-Rich Plasma and Fibrin Glue - Pleural Effusion | Phase 2 | Completed | Daryoush Hamidi Alamdari, PhD | 19 | 2017-05-01 | 2024-06-07 |
| Use of Vasopressin Following the Fontan Operation Vasopressin, Normal Saline - Pleural Effusion, Single-ventricle | Phase 2 / Phase 3 | Completed | Wake Forest University Health Sciences | 12 | 2016-12-01 | 2024-10-24 |
| Intrapleural Docetaxel Administration Using Medical Pleuroscopy in Malignant Effusion With Lung Cancer intrapleural docetaxel administration - Pleural Effusion, Malignant, Non-small Cell Carcinoma | Phase 2 | Completed | Asan Medical Center | 4 | 2016-07-26 | 2019-03-08 |
| Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer metformin hydrochloride, placebo, Chemotherapy - Brenner Tumor, Malignant Ascites | Phase 2 | Completed | University of Chicago | 111 | 2015-02-25 | 2026-03-27 |
| Intrapleural Bevacizumab Injection for Malignant Effusion in Lung Cancer Bevacizumab - Non-small Cell Lung Cancer, Malignant Pleural Effusion | Phase 2 | Completed | Haihong Yang, MD, Pricipal investigator | 22 | 2014-01-01 | 2019-03-29 |
| Cryobiopsy or Forceps Biopsy During Semirigid Thoracoscopy: a Comparative Study cryobiopsy (Autoclavable cryoprobe 20416-032 (ERBE, Germany) Flexible FB-55CD-1 Olympus forceps - Pleural Effusion, Pleural Diseases | Phase 2 / Phase 3 | Completed | The University Clinic of Pulmonary and Allergic Diseases Golnik | 40 | 2011-11-01 | 2015-09-10 |
| Endostar and/or Cisplatin for Treatment of Malignant Pleural Effusion or Ascites Endostar, Cisplatin - Malignant Pleural Effusion, Malignant Ascites | Phase 2 | Completed | Jiangsu Simcere Pharmaceutical Co., Ltd. | 336 | 2011-03-01 | 2014-08-01 |
| Clinical Trial Corticoids For Empyema And Pleural Effusion In Children Dexamethasone, Placebo - Parapneumonic Pleural Effusion, Empyema | Phase 2 | Completed | Hospital Infanta Sofia | 60 | 2010-12-01 | 2015-06-01 |
| Intraperitoneal vs Intravenous Chemotherapy Following Neoadjuvant Chemotherapy in Ovarian Cancer carboplatin, cisplatin, paclitaxel - Fallopian Tube Cancer, Metastatic Cancer | Phase 2 | Completed | Canadian Cancer Trials Group | 275 | 2010-03-03 | 2023-08-28 |
| MK-0646 Insulin Growth Factor 1 Receptor Antibody in Stage IIIb or IV Metastatic Non-Squamous Lung Cancer Arm A: Pemetrexed Cisplatin, Arm B Pemetrexed, Cisplatin and MK-0646 - Non Small Cell Lung Cancer | Phase 2 | Completed | University of Kansas | 27 | 2009-06-01 | 2014-11-07 |
| Triplet Combination First Line Treatment in Non Small Cell Lung Cancer (NSCLC) CBP501 + Cisplatin + Pemetrexed, Cisplatin + Pemetrexed - Metastatic Non-squamous Non Small Cell Lung Cancer | Phase 2 | Completed | CanBas Co. Ltd. | 195 | 2009-04-01 | 2017-05-24 |
| Zactima in Non Small Cell Lung Cancer (NSCLC) ELderly Patients In Combination With or Versus Gemcitabine ZD6474, Vandetanib, Placebo to Match ZD6474, Vandetanib, Gemcitabine - Non Small Cell Lung Cancer | Phase 2 | Completed | Genzyme, a Sanofi Company | 124 | 2008-10-01 | 2016-10-17 |
| Tunneled Pleural Catheter in Partially Entrapped Lung VATS, Talc-Pleurodesis, tunneled pleural drainage, VATS, Talc-pleurodesis - Malignant Pleural Effusion | Phase 2 | Completed | Heidelberg University | 50 | 2008-07-01 | 2022-09-02 |
| Comparison of Thoracoscopic Talc Pleurodesis by Thoracic Epidural or General Anesthesia Non-awake VATS talc pleurodesis, Awake VATS talc pleurodesis - Pleural Effusion | Phase 2 | Completed | University of Rome Tor Vergata | 40 | 2007-11-01 | 2011-11-10 |
| AZD0530 in Treating Patients With Extensive Stage Small Cell Lung Cancer saracatinib - Extensive Stage Small Cell Lung Cancer, Lung Metastases | Phase 2 | Completed | National Cancer Institute (NCI) | 23 | 2007-11-01 | 2017-12-07 |
| FDG-Labeled PET Scan in Planning Chemotherapy in Treating Patients With Stage IIIB or IV Non-Small Cell Lung Cancer carboplatin, docetaxel, gemcitabine hydrochloride - Malignant Pleural Effusion, Stage IIIB Non-small Cell Lung Cancer | Phase 2 | Completed | University of Washington | 55 | 2007-10-01 | 2017-02-10 |
Showing 20 of 28. Sign in to see all of them.
Pleural Effusion, Malignant (17) · Carcinoma, Non-Small-Cell Lung (10) · Lung Neoplasms (4) · Adenocarcinoma of Lung (2) · Carcinoma, Ovarian Epithelial (2) · Empyema (2) · Fallopian Tube Neoplasms (2) · Neoplasm Metastasis (2) · Pericardial Effusion (2) · Adenocarcinoma, Bronchiolo-Alveolar (1) · Ascites (1) · Brenner Tumor (1) · Chylothorax (1) · Chylous Ascites (1)
Respiratory Tract Diseases (28) · Pleural Diseases (27) · Neoplasms (21) · Neoplasms by Site (20) · Respiratory Tract Neoplasms (20) · Thoracic Neoplasms (20) · Pleural Neoplasms (17) · Lung Diseases (13) · Bronchial Neoplasms (11) · Carcinoma, Bronchogenic (11) · Lung Neoplasms (10) · Neoplasms by Histologic Type (6) · Neoplasms, Glandular and Epithelial (5) · Pathologic Processes (5)
Carboplatin (5) · Paclitaxel (5) · Cisplatin (4) · Docetaxel (4) · Gemcitabine (3) · Taxes (3) · Bevacizumab (2) · Cetuximab (2) · Pemetrexed (2) · 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole (1) · Arginine (1) · Arginine Vasopressin (1) · Bortezomib (1) · Cdc25C phosphatase (211-221) (1) · Dexamethasone (1)
National Cancer Institute (NCI) (3) · H. Lee Moffitt Cancer Center and Research Institute (2) · University of Washington (2) · Asan Medical Center (1) · CanBas Co. Ltd. (1) · Canadian Cancer Trials Group (1) · Daryoush Hamidi Alamdari, PhD (1) · Delta University for Science and Technology (1) · Eli Lilly and Company (1) · Genzyme, a Sanofi Company (1) · Haihong Yang, MD, Pricipal investigator (1) · Heidelberg University (1) · Hospital Infanta Sofia (1) · Jiangsu Simcere Pharmaceutical Co., Ltd. (1) · Kidney Cancer Research Bureau (1)
United States (16) · China (2) · Italy (2) · Spain (2) · United Kingdom (2) · Canada (1) · Egypt (1) · Germany (1) · Iran (1) · Russia (1) · Slovenia (1) · South Korea (1)
Alberto Chiappori, MD (1) · Ales Rozman, MD (1) · Chao H Huang, MD, FACP (1) · Daryoush Hamidi-Alamdari, Ph.D (1) · Diane M. Provencher, MD, FRCS, FACOG (1) · Gerold Bepler, MD, PhD (1) · Haihong Yang, MD (1) · Hans Hoffmann, MD, PhD (1) · Helen J. Mackay, MD (1) · Ilya Tsimafeyeu, M.D. (1) · James Spicer, MD (1) · Jamie Penk, MD (1)
PMID 18300255, PMID 23601750, PMID 26793618, PMID 27007334, PMID 28363363, PMID 29186319, PMID 42310706, PMID 42448681
U10CA031946 (2), 2009 (1), R21CA123866 (1), U10CA025224 (1), U10CA180821 (1)